Learn More
Description
Specifications
Specifications
| Antigen | Matriptase/ST14 |
| Applications | Western Blot, Immunoprecipitation |
| Classification | Polyclonal |
| Concentration | 1.0 mg/mL |
| Conjugate | Unconjugated |
| Dilution | Western Blot 1:2000 - 1:10000, Immunoprecipitation 2 - 10 ug/mg lysate |
| Formulation | Tris-Citrate/Phosphate (pH 7.0 - 8.0) with 0.09% Sodium Azide |
| Gene Accession No. | Q9Y5Y6 |
| Gene Alias | EC 3.4.21, HAI, Matriptase, Membrane-type serine protease 1, MT-SP1EC 3.4.21.109, prostamin, PRSS14, Serine protease 14, Serine protease TADG-15, SNC19MTSP1, suppression of tumorigenicity 14 (colon carcinoma), suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin), suppressor of tumorigenicity 14 protein, TADG15, TMPRSS14, tumor associated differentially expressed gene 15 protein, Tumor-associated differentially-expressed gene 15 protein |
| Gene Symbols | ST14 |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
